Letter by He et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)"

Circulation. 2025 Sep 9;152(10):e88. doi: 10.1161/CIRCULATIONAHA.124.073256. Epub 2025 Sep 8.

¹ Department of Cardiology, The Second Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin, China (Z.H.).
² Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China (C.W., H.T.).

No abstract available

Publication types